This migration defect was present in neutrophils from MDS patients that did not have a mutation in spliceosome genes and in neutrophils from patients that had mutations in either the U2AF1 or SF3B1 spliceosome genes (Fig. 6). This evidence concerns the gene U2AF1 and myelodysplastic syndrome.